Icl to acquire the activity of evogene's subsidiary, lavie bio

Lavie bio improves agriculture productivity and sustainability through microbiome-based ag-biological products rehovot, israel , april 21, 2025 /prnewswire/ -- evogene ltd. (nasdaq: evgn) (tase: evgn) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing of a definitive agreement under which icl, will acquire the majority of activity of evogene's subsidiary, lavie bio ltd.
ICL Ratings Summary
ICL Quant Ranking